Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to benefit from atezolizumab DetermaIO...

Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...